SleepWell Trade

Trend-Following Backtester · Guide · backtest 한국어

equity · US

Perspective Therapeutics, Inc. backtest

10 trend-following strategies were compared on the full daily history of Perspective Therapeutics, Inc.. 9 beat buy-and-hold CAGR; ADX / DI 방향성 ranks first by Sharpe, matching the main backtester.

Data 2005-11-10 ~ 2026-07-31daily bars 5,211 (20.7 years)Costs 0.5%Venue XASEMonthly snapshot 2026-07-31

Results by strategy

9 of 10 beat buy and hold (CAGR -12.9%, drawdown -98.2%).

Sharpe leader (same as main): ADX / DI 방향성 — CAGR 13.8%, MDD -86.2%, Sharpe 0.44, 24% exposure.

No strategy retained at least 75% of buy-and-hold CAGR while reducing drawdown by both 20% relatively and 5 percentage points absolutely.

The alternative must retain 75% of buy-and-hold CAGR, improve drawdown by at least 20% and 5 percentage points, and stay below 95% exposure; the ranking weights return retention 60% and drawdown improvement 40%.

Strategy · parametersCAGRMDDSharpeCalmarTotalTradesExposure
ADX / DI 방향성
period=21, threshold=23
13.8%-86.2%0.440.1614.5x8224%
Supertrend
period=11, mult=3.3
7.9%-90.6%0.430.094.8x8242%
볼린저 밴드 돌파
n=31, k=2.9
10.3%-93.9%0.400.117.6x6617%
Donchian 채널 돌파
entryN=23, exitN=79
-4.5%-95.2%0.36-0.050.4x6064%
MACD
fast=15, slow=59, signal=19
-2.3%-99.0%0.35-0.020.6x20649%
SMA 크로스오버
fast=38, slow=49
-2.6%-92.0%0.30-0.030.6x13839%
Parabolic SAR
step=0.015, maxStep=0.22
-6.5%-98.2%0.28-0.070.2x30441%
Keltner 채널 돌파
emaPeriod=35, atrPeriod=12, mult=3.1
1.6%-90.9%0.260.021.4x3811%
ROC 모멘텀
n=20, threshold=0.03
-7.8%-98.6%0.25-0.080.2x48035%
EMA 크로스오버
fast=18, slow=91
-13.4%-98.0%0.10-0.140.1x7634%
Buy and hold-12.9%-98.2%0.39-0.130.1x1100%
0.1 1x 10x 2006 2009 2012 2015 2018 2021 2024 ADX / DI 방향성Buy and hold
ADX / DI 방향성: Solid strategy line versus dashed buy-and-hold line. Log scale.
0% -25% -49% -74% -98% 2006 2009 2012 2015 2018 2021 2024 Buy and holdADX / DI 방향성
ADX / DI 방향성 maximum drawdown -86.2% (2015-05-20 → 2019-10-02), recovered after 2,063 days.

Rules of the top strategy

Looks at both the direction and the strength of the trend; holds only in a strong uptrend.

Method and caveats

Past performance does not guarantee future returns. Parameters were selected on the same full-history sample using sharpe over 40 trials per strategy, so results contain in-sample bias. 0.5% trading costs are included; taxes, slippage and rejected orders are not.
Re-run the same setupMore US assetsAll asset reports

Read next